Edition:
United Kingdom

John Miller

Danish freight firm DSV makes $4 billion play for Panalpina

16 Jan 2019

ZURICH/COPENHAGEN Denmark's DSV has made a $4.1 billion (£3.1 billion) takeover approach to Swiss rival Panalpina to try to close the gap on the world's top three freight transport companies.

Clariant begins 2020 sale plan with search for pigments buyer

10 Jan 2019

FRANKFURT/ZURICH Switzerland's Clariant has begun the sale of its pigments business as part of wider a streamlining which it has said it will complete by the end of 2020, sources said.

Austrian man released after arrest in Turkey in September

24 Dec 2018

ZURICH/ISTANBUL A Turkish court on Monday agreed to release an Austrian student, activist and journalist who was arrested three months ago, but he will have to remain in the country to await judicial proceedings, his lawyer said on Monday.

U.S. body says gene therapy may be more cost effective for spinal muscular atrophy

21 Dec 2018

NEW YORK/ZURICH Biogen Inc's Spinraza treatment for spinal muscular atrophy and Swiss drugmaker Novartis AG's experimental gene therapy are both expensive, but the gene therapy could be more cost effective once more is known about its U.S. price and long-term success rates, a preliminary report from an independent U.S. nonprofit organization said on Thursday.

U.S body says gene therapy may be more cost effective for spinal muscular atrophy

21 Dec 2018

NEW YORK/ZURICH, Dec 20 Biogen Inc's Spinraza treatment for spinal muscular atrophy and Swiss drugmaker Novartis AG's experimental gene therapy are both expensive, but the gene therapy could be more cost effective once more is known about its U.S. price and long-term success rates, a preliminary report from an independent U.S. nonprofit organization said on Thursday.

Novartis oncology boss Barrett makes quick exit

20 Dec 2018

ZURICH Novartis is getting its third oncology chief in less than a year after Liz Barrett said on Thursday she was leaving the Swiss drugmaker to become chief executive of a U.S. biotech firm only 11 months after taking up the role.

UPDATE 1-Novartis oncology boss Barrett makes quick exit

20 Dec 2018

ZURICH, Dec 20 Novartis is getting its third oncology chief in less than a year after Liz Barrett said on Thursday she was leaving the Swiss drugmaker to become chief executive of a U.S. biotech firm only 11 months after taking up the role.

Novartis, China's Gan & Lee push into insulin amid diabetes epidemic

19 Dec 2018

ZURICH Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan & Lee on versions of three blockbuster brands as the U.S. government is seeking to slash insulin costs.

Novartis links with China's Gan & Lee in global insulin push

19 Dec 2018

ZURICH, Dec 19 Swiss drugmaker Novartis aims to become a big player in supplying insulin to diabetics, signing a deal with China's Gan & Lee covering versions of three blockbuster brands just as the U.S. government is seeking to slash insulin costs.

UPDATE 1-Chip industry woes force Switzerland's VAT to extend short work hours

19 Dec 2018

* Analysts fear 2019 could get worse (Adds details, company comment, analyst comment)

World News